Caseware UK (AP4) 2025.0.111 2025.0.111 2025-10-312025-10-312024-11-01falseNo description of principal activity22falsetrueThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.false 12746873 2024-11-01 2025-10-31 12746873 2023-11-01 2024-10-31 12746873 2025-10-31 12746873 2024-10-31 12746873 c:Director1 2024-11-01 2025-10-31 12746873 d:Buildings d:LongLeaseholdAssets 2024-11-01 2025-10-31 12746873 d:Buildings d:LongLeaseholdAssets 2025-10-31 12746873 d:Buildings d:LongLeaseholdAssets 2024-10-31 12746873 d:PlantMachinery 2024-11-01 2025-10-31 12746873 d:PlantMachinery 2025-10-31 12746873 d:PlantMachinery 2024-10-31 12746873 d:PlantMachinery d:OwnedOrFreeholdAssets 2024-11-01 2025-10-31 12746873 d:OwnedOrFreeholdAssets 2024-11-01 2025-10-31 12746873 d:CurrentFinancialInstruments 2025-10-31 12746873 d:CurrentFinancialInstruments 2024-10-31 12746873 d:CurrentFinancialInstruments d:WithinOneYear 2025-10-31 12746873 d:CurrentFinancialInstruments d:WithinOneYear 2024-10-31 12746873 d:ShareCapital 2025-10-31 12746873 d:ShareCapital 2024-10-31 12746873 d:RetainedEarningsAccumulatedLosses 2025-10-31 12746873 d:RetainedEarningsAccumulatedLosses 2024-10-31 12746873 c:FRS102 2024-11-01 2025-10-31 12746873 c:AuditExempt-NoAccountantsReport 2024-11-01 2025-10-31 12746873 c:FullAccounts 2024-11-01 2025-10-31 12746873 c:PrivateLimitedCompanyLtd 2024-11-01 2025-10-31 12746873 e:PoundSterling 2024-11-01 2025-10-31 iso4217:GBP xbrli:pure

Registered number: 12746873










VALENTINE BLOODSTOCK LTD








UNAUDITED

FINANCIAL STATEMENTS

INFORMATION FOR FILING WITH THE REGISTRAR

FOR THE YEAR ENDED 31 OCTOBER 2025

 
VALENTINE BLOODSTOCK LTD
REGISTERED NUMBER: 12746873

BALANCE SHEET
AS AT 31 OCTOBER 2025

2025
2024
Note
£
£

Fixed assets
  

Tangible assets
 4 
426,808
139,680

  
426,808
139,680

Current assets
  

Stocks
  
56,207
40,279

Debtors: amounts falling due within one year
 5 
13,255
105

Cash at bank and in hand
 6 
43,790
53,577

  
113,252
93,961

Creditors: amounts falling due within one year
 7 
(527,835)
(217,163)

Net current liabilities
  
 
 
(414,583)
 
 
(123,202)

Total assets less current liabilities
  
12,225
16,478

  

Net assets
  
12,225
16,478


Capital and reserves
  

Called up share capital 
  
100
100

Profit and loss account
  
12,125
16,378

  
12,225
16,478


The directors consider that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the statement of income and retained earnings in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 28 July 2026.




Edward Partridge
Director
Page 1

 
VALENTINE BLOODSTOCK LTD
REGISTERED NUMBER: 12746873

BALANCE SHEET (CONTINUED)
AS AT 31 OCTOBER 2025


The notes on pages 3 to 6 form part of these financial statements.

Page 2

 
VALENTINE BLOODSTOCK LTD
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 OCTOBER 2025

1.


General information

Valentine Bloodstock Limited is a private company, limited by shares, domiciled in England and Wales. Its registered office is 2 Michaels Court, Hanney Road, Southmoor, Oxon, OX13 5HR.

The company's trading address is Little Oakwell Stud, Kings Nympton, Devon, EX37 9TE.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the requirements and the Companies Act 2006 and the requirements of the Statement of Recommended Practice 'Accounting by Limited Liabilities Partnerships'. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The following principal accounting policies have been applied:

 
2.2

Revenue

Revenue is recognised to the extent that it is probable that the economic benefits will flow to the Company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before revenue is recognised:

Sale of goods

Revenue from the sale of goods is recognised when all of the following conditions are satisfied:
the Company has transferred the significant risks and rewards of ownership to the buyer;
the Company retains neither continuing managerial involvement to the degree usually associated with ownership nor effective control over the goods sold;
the amount of revenue can be measured reliably;
it is probable that the Company will receive the consideration due under the transaction; and
the costs incurred or to be incurred in respect of the transaction can be measured reliably.

Rendering of services

Revenue from a contract to provide services is recognised in the period in which the services are provided in accordance with the stage of completion of the contract when all of the following conditions are satisfied:
the amount of revenue can be measured reliably;
it is probable that the Company will receive the consideration due under the contract;
the stage of completion of the contract at the end of the reporting period can be measured reliably; and
the costs incurred and the costs to complete the contract can be measured reliably.

Page 3

 
VALENTINE BLOODSTOCK LTD
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 OCTOBER 2025

2.Accounting policies (continued)

 
2.3

Operating leases: the Company as lessee

Rentals paid under operating leases are charged to profit or loss on a straight-line basis over the lease term.

Benefits received and receivable as an incentive to sign an operating lease are recognised on a straight-line basis over the lease term, unless another systematic basis is representative of the time pattern of the lessee's benefit from the use of the leased asset.

 
2.4

Finance costs

Finance costs are charged to profit or loss over the term of the debt using the effective interest method so that the amount charged is at a constant rate on the carrying amount. Issue costs are initially recognised as a reduction in the proceeds of the associated capital instrument.

 
2.5

Tangible fixed assets

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, using the straight-line method.

Depreciation is provided on the following basis:

Long-term leasehold property
-
Plant and machinery
-
15%

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.

 
2.6

Stocks

Stocks are stated at the lower of cost and net realisable value, being the estimated selling price less costs to complete and sell. Cost is based on the cost of purchase on a first in, first out basis. Work in progress and finished goods include labour and attributable overheads.

At each balance sheet date, stocks are assessed for impairment. If stock is impaired, the carrying amount is reduced to its selling price less costs to complete and sell. The impairment loss is recognised immediately in profit or loss.

 
2.7

Debtors

Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

Page 4

 
VALENTINE BLOODSTOCK LTD
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 OCTOBER 2025

2.Accounting policies (continued)

 
2.8

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

 
2.9

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

 
2.10

Dividends

Equity dividends are recognised when they become legally payable. Interim equity dividends are recognised when paid. Final equity dividends are recognised when approved by the shareholders at an annual general meeting.


3.


Employees

The average monthly number of employees, including directors, during the year was 2 (2024 - 2).


4.


Tangible fixed assets


Long-term leasehold property
Plant and machinery
Total

£
£
£



Cost or valuation


At 1 November 2024
97,187
59,413
156,600


Additions
265,785
29,816
295,601



At 31 October 2025

362,972
89,229
452,201



Depreciation


At 1 November 2024
-
16,920
16,920


Charge for the year on owned assets
-
8,473
8,473



At 31 October 2025

-
25,393
25,393



Net book value



At 31 October 2025
362,972
63,836
426,808



At 31 October 2024
97,187
42,493
139,680

Page 5

 
VALENTINE BLOODSTOCK LTD
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 OCTOBER 2025

5.


Debtors

2025
2024
£
£


Trade debtors
-
105

Other debtors
13,255
-

13,255
105



6.


Cash and cash equivalents

2025
2024
£
£

Cash at bank and in hand
43,790
53,577

43,790
53,577



7.


Creditors: Amounts falling due within one year

2025
2024
£
£

Trade creditors
4,665
-

Other taxation and social security
-
3,628

Other creditors
522,537
207,341

Accruals and deferred income
633
6,194

527,835
217,163



Page 6